ArticlePDF Available

Prevalence of neck pain and its associated factors in Africa: a systematic review and meta-analysis protocol

BMJ Group
BMJ Open
Authors:

Abstract

Introduction Neck pain is one of the most prevalent musculoskeletal pain conditions with multifactorial impact including pain, disability and reduced quality of life. To the best of our knowledge, no systematic review and meta-analysis is available to provide reliable data on the pooled prevalence of neck pain and its associated factors in Africa. Thus, the objective of this study is to describe a protocol for a systematic review and meta-analysis on the prevalence of neck pain and its associated factors in Africa. Methods This systematic review protocol has been designed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P). A systematic search will be conducted among six key electronic databases including PubMed/MEDLINE, Scopus, African Journals Online, EMBASE, CINAHL and Web of Science, from inception onwards. Population-based cross-sectional studies reporting prevalence of neck pain in the African continent will be included. The primary outcome will be the prevalence of neck pain, whereas the secondary outcomes will be the factors associated with neck pain prevalence. Two independent reviewers will screen the titles/abstracts and relevant full-text articles of potentially relevant studies. Data from eligible studies will be extracted using a customised data extraction form. The risk of bias and methodological quality of the included studies will be assessed using the Newcastle–Ottawa Scale and critical appraisal tool, respectively. A narrative synthesis will be used to summarise the prevalence estimates of neck pain and associated factors. However, if feasible, random-effects meta-analysis will be conducted with Revman V.5.4 software. Additionally, subgroup, sensitivity and publication bias analyses will be conducted. Discussion This will be the first systematic review and meta-analysis to systematically identify and synthesise available literature on the prevalence of neck pain and its associated factors in Africa. The results of this review may assist health professionals and policymakers to plan and implement evidence-based strategies that will lessen the burden of neck pain. Ethics and dissemination Data from previously published studies will be collected and analysed and hence ethical approval will not be sought for this study. The results of this review will be disseminated through publication in a peer-reviewed academic journal and presentation at relevant academic conferences. PROSPERO registration number CRD42021273585.
1
MukhtarNB, etal. BMJ Open 2023;13:e074219. doi:10.1136/bmjopen-2023-074219
Open access
Prevalence of neck pain and its
associated factors in Africa: a systematic
review and meta- analysis protocol
Naziru Bashir Mukhtar,1,2 Aminu Alhassan Ibrahim ,3 Jibril Mohammed 1
To cite: MukhtarNB,
IbrahimAA, MohammedJ.
Prevalence of neck pain and its
associated factors in Africa: a
systematic review and meta-
analysis protocol. BMJ Open
2023;13:e074219. doi:10.1136/
bmjopen-2023-074219
Prepublication history and
additional supplemental material
for this paper are available
online. To view these les,
please visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2023-074219).
Received 31 March 2023
Accepted 30 August 2023
1Department of Physiotherapy,
Faculty of Allied Health
Sciences, College of Health
Sciences, Bayero University,
Kano, Nigeria
2Department of Physiotherapy,
School of Health Sciences,
Maryam Abacha American
University of Nigeria, Kano,
Nigeria
3Department of Physiotherapy,
School of Basic Medical
Sciences, Skyline University
Nigeria, Kano, Nigeria
Correspondence to
Dr Aminu Alhassan Ibrahim;
amenconafs@ gmail. com
Protocol
© Author(s) (or their
employer(s)) 2023. Re- use
permitted under CC BY- NC. No
commercial re- use. See rights
and permissions. Published by
BMJ.
ABSTRACT
Introduction Neck pain is one of the most prevalent
musculoskeletal pain conditions with multifactorial impact
including pain, disability and reduced quality of life. To
the best of our knowledge, no systematic review and
meta- analysis is available to provide reliable data on the
pooled prevalence of neck pain and its associated factors
in Africa. Thus, the objective of this study is to describe
a protocol for a systematic review and meta- analysis on
the prevalence of neck pain and its associated factors in
Africa.
Methods This systematic review protocol has been
designed in accordance with the Preferred Reporting
Items for Systematic Reviews and Meta- Analyses
Protocols (PRISMA- P). A systematic search will be
conducted among six key electronic databases
including PubMed/MEDLINE, Scopus, African Journals
Online, EMBASE, CINAHL and Web of Science, from
inception onwards. Population- based cross- sectional
studies reporting prevalence of neck pain in the African
continent will be included. The primary outcome will be
the prevalence of neck pain, whereas the secondary
outcomes will be the factors associated with neck pain
prevalence. Two independent reviewers will screen
the titles/abstracts and relevant full- text articles of
potentially relevant studies. Data from eligible studies
will be extracted using a customised data extraction
form. The risk of bias and methodological quality of the
included studies will be assessed using the Newcastle–
Ottawa Scale and critical appraisal tool, respectively.
A narrative synthesis will be used to summarise the
prevalence estimates of neck pain and associated factors.
However, if feasible, random- effects meta- analysis will
be conducted with Revman V.5.4 software. Additionally,
subgroup, sensitivity and publication bias analyses will be
conducted.
Discussion This will be the rst systematic review and
meta- analysis to systematically identify and synthesise
available literature on the prevalence of neck pain and its
associated factors in Africa. The results of this review may
assist health professionals and policymakers to plan and
implement evidence- based strategies that will lessen the
burden of neck pain.
Ethics and dissemination Data from previously
published studies will be collected and analysed and
hence ethical approval will not be sought for this study.
The results of this review will be disseminated through
publication in a peer- reviewed academic journal and
presentation at relevant academic conferences.
PROSPERO registration number CRD42021273585.
INTRODUCTION
Musculoskeletal disorders are common and
burdensome health problems contributing
to disability,1 2 with about 1.71 billion people
being affected globally.3 Neck pain, being
second only to low back pain as the most
prevalent musculoskeletal pain condition,4
is a complex disorder with a multifactorial
impact including pain, disability and reduced
quality of life.5 Neck pain causes a substantial
burden not only to sufferers and their families
but also to society due to the costs associated
with healthcare, insurance, work absenteeism
and loss of productivity.5 6
The occurrence and chronicity of neck
pain are believed to be multifaceted,7 with
individual/personal (eg, age, sex, body mass
index and smoking), biomechanical (eg,
strenuous physical activity, faulty postures)
and psychosocial (eg, stress, anxiety and
depression) factors being commonly impli-
cated.8–10 However, the development and
impact of neck pain are likely to vary signifi-
cantly between and within population groups
owing to social, economic, cultural and envi-
ronmental influence.
According to the most recent Global
Burden of Disease estimates, the global
prevalence and incidence of neck pain have
STRENGTHS AND LIMITATIONS OF THIS STUDY
This protocol denes the rst systematic review
with meta- analysis to synthesise the prevalence of
neck pain and its associated factors in Africa.
Findings of this review will provide information to
health professionals and policymakers in planning
and implementing evidence- based strategies for
lessening the burden of neck pain in Africa.
The plan to conduct a meta- analysis, subgroup and
sensitivity analyses, as well as inclusion of all age
groups, are the strengths of this review.
Language restriction to studies published in English
or French may be a limitation.
on September 19, 2023 by guest. Protected by copyright.http://bmjopen.bmj.com/BMJ Open: first published as 10.1136/bmjopen-2023-074219 on 18 September 2023. Downloaded from
2MukhtarNB, etal. BMJ Open 2023;13:e074219. doi:10.1136/bmjopen-2023-074219
Open access
increased from 124.4 million and 276.5 million cases
in 1990 to about 222.7 million and 475.2 million cases
in 2019, respectively.11 Neck pain remained one of the
leading causes of disability in most parts of the world in
2015.1 Moreover, among different conditions, it contrib-
utes to the highest healthcare expenditure related to
musculoskeletal disorders, where about $134.5 billion
was reported to have been spent in the USA in the year
2016.12 This poses a serious problem to the contemporary
society.
The burden of neck pain in terms of years lived with
disability is higher in women than in men, but increases
with age in both genders, peaking at 45–54 years of age,
before declining around the age of 70–74 years.11 This is
indicative of the significant role of ageing as a contributing
factor to the burden of the disease, which unfortunately,
is likely to be increasingly overwhelming in the coming
decades. In low- income countries, especially those on the
African continent, where population growth and ageing
are increasing at a very fast pace, this may be an issue to
contend with in the future.13 Moreover, the current wide-
spread limited healthcare resources, low socioeconomic
status, and ineffective or lack of preventive strategies in
these countries also make the situation even more dire.14
In sub- Saharan Africa, the point prevalence of neck
pain is high (males 4.1–4.7%; females 6.0–6.8%) and
only outranked by the USA (males 5.3%; females 7.6%),
Western Europe (males 5.2%; females 7.4%) and East
Asia (males 4.8%; females 7.0%).5 Unless effective
prevention strategies are implemented, the burden of
neck pain in Africa is likely to be disturbing in the next
few years. Unfortunately, despite the staggering impact
of neck pain, it is generally less prioritised and empiri-
cally presented,5 15 possibly due to the overwhelming inci-
dence of life- threatening conditions such as malaria and
HIV/AIDS.16 However, epidemiological challenges and
unavailability of reliable data on the prevalence estimates
could possibly explain why disabling musculoskeletal
conditions are generally less prioritised in Africa. Thus,
to have a better understanding of the impact of neck pain
for policymaking, resource allocation and effective trans-
lation of research findings into clinical practice in this
continent, reliable data on the pooled prevalence of neck
pain and its associated factors are warranted.
As is the usual trend globally, low back pain is mostly
prioritised over neck pain in research despite the huge
global burden of both disorders.5 17 In this regard, a
systematic review and meta- analysis on the prevalence
of low back pain in Africa was conducted in 201718 and
updated in 2018.19 This review has opened doors for
low back pain- related research and policies. However, a
similar review on neck pain in Africa, despite its burden
and a plethora of published cross- sectional studies, is
lacking.
Following our preliminary search in the International
Prospective Register of Systematic Reviews (PROSPERO),
MEDLINE, PEDro and the Cochrane Database of System-
atic Reviews, it is apparent that no current or underway
systematic review and meta- analysis on the prevalence of
neck pain and its associated factors in Africa exits. There-
fore, the objective of this study is to describe a protocol
for a systematic review and meta- analysis on the preva-
lence of neck pain and its associated factors in Africa.
Specific objectives of this review are:
To provide accurate and contemporary prevalence
estimates of neck pain in Africa according to existing
published studies.
To examine the factors associated with neck pain
prevalence in Africa according to existing published
studies.
To critically appraise the methodological quality of
the prevalence studies to identify gaps in the litera-
ture and highlight areas for improvement in future
research.
METHODS
Systematic review registration and reporting
This review protocol has been registered with the PROS-
PERO database on 14 September 2021 (registration
number CRD42021273585) and designed in accordance
with the Preferred Reporting Items for Systematic Reviews
and Meta- Analyses Protocols (PRISMA- P) statement20
(online supplemental appendix 1) and Meta- analysis
Of Observational Studies in Epidemiology (MOOSE)
reporting guideline.21 In the event of an amendment to
this protocol, a description of the amendment along with
the rationale will be updated in PROSPERO.
Data sources and search strategies
Six key electronic databases will be systematically searched
from inception to obtain and export relevant articles
reporting the prevalence of neck pain in the African
continent. The databases are PubMed/MEDLINE,
Scopus, African Journals Online, EMBASE, CINAHL
and Web of Science. Appropriate search strategies will
be used for each of the databases to ensure maximum
number of relevant articles. The keywords will be ‘preva-
lence’, ‘neck pain’, ‘musculoskeletal disorders/pain’ and
‘Africa’. Logically, we anticipate that there will be a lack
of the word ‘Africa’ quoted in the title of body of most
potentially relevant African prevalence studies. Hence, all
individual African countries names will be included in the
search strategies. For studies reporting musculoskeletal
disorders/pain, neck pain prevalence has to be reported
for the study to be included. The full search strategy is
presented online supplemental appendix 2.
Eligibility criteria
Studies will be included in the review according to the
following criteria: participants, condition or outcome(s)
of interest, study design and context. The primary focus of
the review is to estimate the prevalence of neck pain in the
African continent. Therefore, studies that were conducted
in any of the African countries and have reported data on
the prevalence of neck pain will be eligible for inclusion.
Eligible studies will be population- based cross- sectional
on September 19, 2023 by guest. Protected by copyright.http://bmjopen.bmj.com/BMJ Open: first published as 10.1136/bmjopen-2023-074219 on 18 September 2023. Downloaded from
3
MukhtarNB, etal. BMJ Open 2023;13:e074219. doi:10.1136/bmjopen-2023-074219
Open access
studies reporting prevalence data using validated or
non- validated questionnaire/scale and conducted in the
African continent.
Due to the frequency of studies conducted on muscu-
loskeletal disorders and musculoskeletal pain among
African researchers, such studies will be included due
to the presence of neck pain in the data of such studies.
This will be in addition to studies reporting primarily
on neck pain. To be included, studies have to report
on prevalence (often proportion) of neck pain in the
population of interest. Parameters such as age, gender,
language or ethnic group of the participants will not be
a barrier for inclusion. However, only studies published
in English or French will be eligible since these are the
common languages used in scholarly communication in
Africa.19 22 Studies published in French will be translated
by a French- speaking African native and will be validated
by cross- checking the French translations with the English
abstract of the article, which is often available online,
before inclusion. Studies published in other languages
other than English and French will be excluded. Lastly,
reviews, conference abstracts, commentaries/letter to
editors, non- human articles and other grey literature will
also be excluded.
Condition or outcome(s) of interest
Primary outcome for the present review will be preva-
lence proportion of neck pain, defined according to the
author’s reported definition. Secondary outcomes will be
to identify the factors (eg, individual/personal, biome-
chanical and psychosocial factors) associated with neck
pain prevalence. In the event that neck pain prevalence
is not directly reported in proportion and associated
95% CI, estimates from the number of cases and sample
size mentioned in each single study will be calculated, if
permissible.
Study screening and selection
Relevant articles will first be exported to Zotero soft-
ware (https://www.zotero.org), where articles will be
sorted and duplicates removed before being exported
to the Rayyan software (https://rayyan.qcri.org) for
screening. The first author (NBM) who is experienced
in conducting and publishing systematic reviews as first
and coauthor, together with the second author (AAI)
who recently completed an intensive course on how to
conduct systematic reviews and meta- analyses, will inde-
pendently screen the articles. In case of unresolved
conflict, the third author (JM) will help in resolving the
conflict. JM has published a number of systematic reviews
as first author. Additional co- authors with experience in
conducting systematic reviews will be invited depending
on the amount of work load encountered from the data-
bases search. Both title/abstract and full- text screening
will be performed using the Rayyan software. A planned
PRISMA flow chart showing details of the included and
excluded studies at each stage of the study selection
process is provided in figure 1.
Data extraction and management
Information to be extracted from the eligible studies will
include author name(s), year of publication, country of
publication, study design, data collection tool/outcome
measure tool(s), population, study setting, sample size,
age group/age (range and/or mean±SD), gender,
data collection period, neck pain definition, neck pain
recall period, reliability/validity of measurement tools,
response rates, neck pain prevalence rates (point, period,
lifetime) and associated or risk factors of neck pain with
their OR. The corresponding authors will be contacted
through mail when necessary for any difficulties encoun-
tered during data extraction. A prepared customised
data extraction form will be used for entering the rele-
vant publication details. The findings of the review will be
illustrated through tables and figures.
Risk of bias and methodological quality assessment
The Newcastle–Ottawa Scale (NOS) which consists of
three domains (selection, comparability and outcome)
will be used in assessing the risk of bias (ROB) in
the included studies. A checklist and coding manual
language specific to the current review topic will be
prepared to aid the two independent raters during ROB
assessment. When a primary study meets the method-
ological expected standard, one star will be awarded
for each item in selection and outcome domains, and a
maximum of two stars will be awarded for the compara-
bility domain. In the end, studies with star scores from
0 to 4 points will be considered as having high ROB,
Figure 1 Flow chart depicting study selection process.
on September 19, 2023 by guest. Protected by copyright.http://bmjopen.bmj.com/BMJ Open: first published as 10.1136/bmjopen-2023-074219 on 18 September 2023. Downloaded from
4MukhtarNB, etal. BMJ Open 2023;13:e074219. doi:10.1136/bmjopen-2023-074219
Open access
5 to 6 points will be considered as having moderate
ROB, while 7 to 9 points will be considered as having
low ROB.23
Additionally, the quality of the included studies will
also be appraised using a critical appraisal tool as modi-
fied by Morris et al19 (online supplemental appendix 3)
where low back pain prevalence in Africa was reviewed
and methodological quality of the included studies was
appraised using the same tool. We consider this tool to be
additionally appropriate for our review due to the simi-
larity of both reviews. Both low back pain and neck pain
are types of spinal pain and in both reviews, Africa is the
target scope while observational/cross- sectional studies
are the designs of interest. In our review, the only modi-
fication to the appraisal tool will be to replace low back
pain with neck pain. The tool has 10 questions that will
be weighed and scored equally. Each question is to be
answered by either a ‘yes’ or ‘no’ or ‘unclear’. An option
of ‘yes’ will be scored as 1 point, while an option of either
‘no’ or ‘unclear’ connotes 0 point.
Two assessors (most probably NBM and AAI) will inde-
pendently score the ROB (using NOS) and methodolog-
ical quality of the included studies. In case of conflicts, a
meeting will be organised between the two assessors and
where a conflict remains unresolved after the meeting,
the last author (JM) will be invited to make the final
decision.
Strategy for data synthesis
A descriptive table summarising the key characteristics
of each of the included studies will be presented. Meta-
analysis will be planned with sufficient clinically and statis-
tically homogeneous and comparable reported outcomes
among studies by pooling data using Revman V.5.4 soft-
ware. The pooled prevalence estimates of neck pain in
Africa and associated 95% CI will be calculated. Similarly,
for the factors associated with neck pain prevalence, OR
and associated 95% CI will be computed. Random- effects
model will be used since heterogeneity in the popula-
tions of included studies is expected. Statistical hetero-
geneity will be assessed using I² statistic and its 95% CI,
with values of 25, 50, and 75% signifying mild, moderate,
and severe heterogeneity, respectively.24 25 Pooled preva-
lence estimates will be graphically depicted using forest
plots. In case meta- analysis is not possible due to insuffi-
cient homogeneous studies, a narrative synthesis will be
performed.
Assessment of publication bias
Potential publication bias will be assessed subjectively
using funnel plots, with a symmetrical funnel shape indi-
cating no publication bias while an asymmetrical funnel
plot indicating a publication bias.26 Objective assessment
of publication bias will be performed using Egger’s linear
regression test, with p<0.1 indicating statistically signifi-
cant publication bias.27
Subgroup and sensitivity analyses
Based on the study and population characteristics,
subgroup analyses will be performed for age group (adults
and children/adolescents), gender (male and female),
study setting (community, industry, hospital, professional
and school) and country status (low income, low middle
income and upper middle income) as also examined in
previous reviews in Africa.18 19 For sensitivity analyses,
studies with lower methodological quality studies will be
excluded to assess if their exclusion would change the
results of the analyses.
Patient and public involvement
This study involves a review of publicly available published
peer- reviewed papers; hence, patients and the public were
not involved.
Ethics and dissemination
Ethical approval will not be sought for this study, as no
human subject participants will be involved. Data from
previously published studies will be collected and anal-
ysed. The results of this review will be disseminated
through publication in a peer- reviewed academic journal
and presentation at relevant academic conferences.
DISCUSSION
Neck pain remains one of the common health problems
affecting the contemporary society. However, despite
the significant disability and socioeconomic burden
imposed by neck pain, still, less is known about its impact
in the African context, perhaps because it is not a life-
threatening condition.28 To our best knowledge, this will
be the first review to systematically identify and synthe-
sise available literature on the prevalence and associated
factors of neck pain in the African continent. Therefore,
this will be the first systematic review and meta- analysis
to provide a pooled prevalence of neck pain and its asso-
ciated factors on the African continent, which may assist
health professionals and policymakers to plan and imple-
ment evidence- based strategies for lessening the burden
of neck pain. Furthermore, the review will identify the
methodological shortcomings of published African
studies on neck pain prevalence for improvement of
future research quality.
The plan to conduct a meta- analysis, subgroup and
sensitivity analyses are the major strengths of our review.
Additionally, the inclusion of all age groups will increase
the generalisability of the findings. However, we antici-
pate limitations to our review due to potential publica-
tion bias and heterogeneity among studies, as well as the
inclusion of only published studies in English or French.
Contributors NBM conceived the research question and designed the study with
the help of other authors. AAI developed and edited the protocol. NBM and AAI will
design the search strategy, participate in the search process, appraise the quality of
the articles and extract needed data independently. NBM and JM will analyse and
interpret the results. JM will supervise the review. All authors read and approve this
protocol before sending it for publication.
on September 19, 2023 by guest. Protected by copyright.http://bmjopen.bmj.com/BMJ Open: first published as 10.1136/bmjopen-2023-074219 on 18 September 2023. Downloaded from
5
MukhtarNB, etal. BMJ Open 2023;13:e074219. doi:10.1136/bmjopen-2023-074219
Open access
Funding The authors have not declared a specic grant for this research from any
funding agency in the public, commercial or not- for- prot sectors.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in
the design, or conduct, or reporting, or dissemination plans of this research.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has
not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been
peer- reviewed. Any opinions or recommendations discussed are solely those
of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and
responsibility arising from any reliance placed on the content. Where the content
includes any translated material, BMJ does not warrant the accuracy and reliability
of the translations (including but not limited to local regulations, clinical guidelines,
terminology, drug names and drug dosages), and is not responsible for any error
and/or omissions arising from translation and adaptation or otherwise.
Open access This is an open access article distributed in accordance with the
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which
permits others to distribute, remix, adapt, build upon this work non- commercially,
and license their derivative works on different terms, provided the original work is
properly cited, appropriate credit is given, any changes made indicated, and the use
is non- commercial. See:http://creativecommons.org/licenses/by-nc/4.0/.
ORCID iDs
Aminu AlhassanIbrahim http://orcid.org/0000-0002-5711-1639
JibrilMohammed http://orcid.org/0000-0001-7466-7973
REFERENCES
1 Vos T, Allen C, Arora M. Global, regional, and national incidence,
prevalence, and years lived with disability for 310 diseases and
injuries, 1990- 2015: a systematic analysis for the Global Burden of
Disease Study 2015. Lancet 2016;388:1545–602.
2 Kyu HH, Abate D, Abate KH, etal. Global, regional, and national
disability- adjusted life- years (DALYs) for 359 diseases and injuries
and healthy life expectancy (HALE) for 195 countries and territories,
1990- 2017: a systematic analysis for the Global Burden of Disease
Study 2017. The Lancet 2018;392:1859–922.
3 Cieza A, Causey K, Kamenov K, etal. Global estimates of the need
for rehabilitation based on the global burden of disease study 2019:
a systematic analysis for the Global Burden of Disease Study 2019.
Lancet 2021;396:2006–17.
4 March L, Smith EUR, Hoy DG, etal. Burden of disability due to
musculoskeletal (MSK) disorders. Best Pract Res Clin Rheumatol
2014;28:353–66.
5 Hoy D, March L, Woolf A, etal. The global burden of neck pain:
estimates from the Global Burden of Disease 2010 study. Ann Rheum
Dis 2014;73:1309–15.
6 Haldeman S, Carroll L, Cassidy JD. Findings from the bone and joint
decade 2000 to 2010 task force on neck pain and its associated
disorders. J Occup Environ Med 2010;52:424–7.
7 Blanpied PR, Gross AR, Elliott JM, etal. Neck pain: revision 2017. J
Orthop Sports Phys Ther 2017;47:A1–83.
8 Hogg- Johnson S, van der Velde G, Carroll LJ, etal. The burden and
determinants of neck pain in the general population: results of the
bone and joint decade 2000- 2010 task force on neck pain and its
associated disorders. Spine (Phila Pa 1976) 2008;33:S39–51.
9 Croft PR, Lewis M, Papageorgiou AC, etal. Risk factors for
neck pain: a longitudinal study in the general population. Pain
2001;93:317–25.
10 Kazeminasab S, Nejadghaderi SA, Amiri P, etal. Neck pain: global
epidemiology, trends and risk factors. BMC Musculoskelet Disord
2022;23:26.
11 Shin DW, Shin JI, Koyanagi A, etal. Global, regional, and national
neck pain burden in the general population, 1990–2019: an
analysis of the Global Burden of Disease Study 2019. Front Neurol
2022;13:955367.
12 Dieleman JL, Cao J, Chapin A, etal. US health care spending by
payer and health condition, 1996- 2016. JAMA 2020;323:863.
13 Kibirige JS. Population growth, poverty and health. Soc Sci Med
1997;45:247–59.
14 Azevedo MJ. The state of health System(S) in Africa: challenges
and opportunities. In: Historical perspectives on the state of health
and health systems in Africa, Volume II. Cham: Palgrave Macmillan,
2017: 1–73.
15 Wanyonyi NEN, Frantz J. Prevalence of work- related musculoskeletal
disorders in Africa: a systematic review. Physiotherapy
2015;101:e1604–5.
16 Moszynski P. WHO report highlights Africa’s health challenges. BMJ
2006;333:1088.
17 Hoy D, March L, Brooks P, etal. The global burden of low back pain:
estimates from the Global Burden of Disease 2010 study. Ann Rheum
Dis 2014;73:968–74.
18 Louw QA, Morris LD, Grimmer- Somers K. The prevalence of low
back pain in Africa: a systematic review. BMC Musculoskelet Disord
2007;8:105.
19 Morris LD, Daniels KJ, Ganguli B, etal. An update on the prevalence
of low back pain in Africa: a systematic review and meta- analyses.
BMC Musculoskelet Disord 2018;19:196.
20 Moher D, Shamseer L, Clarke M, etal. Preferred reporting items for
systematic review and meta- analysis protocols (PRISMA- P) 2015
statement. Syst Rev 2015;4:1.
21 Stroup DF, Berlin JA, Morton SC, etal. Meta- analysis of
observational studies in epidemiology: a proposal for reporting.
Meta- analysis of observational studies in epidemiology (MOOSE)
group. JAMA 2000;283:2008–12.
22 Ondari- Okemwa E. Scholarly publishing in sub- Saharan Africa in the
twenty- rst century: challenges and opportunities. FM 2007;12:10.
23 Mamikutty R, Aly AS, Marhazlinda J. Selecting risk of bias tools for
observational studies for a systematic review of anthropometric
measurements and dental caries among children. Int J Environ Res
Public Health 2021;18:8623.
24 Higgins JPT, Thompson SG, Deeks JJ, etal. Measuring
inconsistency in meta- analyses. BMJ 2003;327:557–60.
25 Huedo- Medina TB, Sánchez- Meca J, Marín- Martínez F, etal.
Assessing heterogeneity in meta- analysis: Q Statistic or I2 index
Psychol Methods 2006;11:193–206.
26 Sterne JA, Egger M. Funnel plots for detecting bias in meta- analysis:
guidelines on choice of axis. J Clin Epidemiol 2001;54:1046–55.
27 Egger M, Davey Smith G, Schneider M, etal. Bias in meta- analysis
detected by a simple, graphical test. BMJ 1997;315:629–34.
28 Woolf AD, Brooks P, Akesson K, etal. Prevention of musculoskeletal
conditions in the developing world. Best Pract Res Clin Rheumatol
2008;22:759–72.
on September 19, 2023 by guest. Protected by copyright.http://bmjopen.bmj.com/BMJ Open: first published as 10.1136/bmjopen-2023-074219 on 18 September 2023. Downloaded from
... (1) As it is a complex and recurrent disorder, it has a strong tendency to chronicity, tending to generate pain, limitation of activities of daily living, incapacity for work activities and reduced Quality of Life (QoL). (3,4) Quality of life can be defined as the individual's perception of his position in life, in the context of the culture and value system in which he lives, and in relation to his goals, expectations, standards and concerns, and can be evaluated in various ways. (5,6) Among the various QoL assessment instruments, the abbreviated version of the WHOQOL-Bref has been widely used, as it is easy to apply and addresses physical, psychological, social and environmental aspects, as well as general quality of life. ...
... They negatively impact the physical and mental health and overall quality of life of health professionals. (4,15) Nevertheless, during the pandemic period there was a mix of feelings capable of enhancing existing pains, due to the environment and work routine, or contributing to the emergence of new pains. ...
Article
Full-text available
Objective. To analyze the repercussions of neck pain on the quality of life of health professionals in intensive care units. Methods. Cross-sectional, descriptive and correlational study, carried out with 94 health professionals (21 nurses, 13 physical therapists and 60 nursing technicians) in Intensive Care Units of two medium-sized hospitals in a municipality in the far south of Brazil. An instrument containing variables of sociodemographic and work environment characterization was applied; the Neck Bournemouth Questionnaire (NBQ) and the WHOQOL-Bref were applied. Results. There was a predominance of female professionals (88.3%), white (78.8%), aged 30 to 39 years (34.1%), with family income between one and two minimum wages (31.9%) and weekly workload between 31 and 40 hours (67%), night shift (54.3%), time of professional experience of one to five years (38.3%) and one job (73.4%). Neck pain and disability showed significant negative correlations with quality of life. The relationship was weak with the physical (r: -0.218; p=0.035) and psychological (r: -0.280; p=0.006) domains, and moderate with social relationships (r: -0.419; p<0.001), environment (r: -0.280; p<0.001) and general quality of life (r: -0.280; p<0.001). Overall quality of life showed a moderate correlation with the feeling of anxiety (r: -0.431; p<0.001) and depression (r: -0.515; p<0.001) of professionals in the last week. Conclusion. Neck pain caused repercussions in the physical, psychological, social, environmental and general quality of life of health professionals in intensive care units.
... Moreover, prolonged sitting and repetitive movements increase the mechanical demand on cervical structures, inducing inflammatory changes in the bursa and tendons, and potentially contributing to conditions such as degenerative disc disease or cervical spondylosis (9). While acute neck pain may resolve within four weeks, a significant proportion of individuals transition into moderate (4-12 weeks) or chronic (>12 weeks) phases without appropriate ergonomic intervention and muscular rehabilitation (10). These chronic manifestations are particularly debilitating as they disrupt sleep, limit physical activity, and reduce work performance. ...
Article
Full-text available
Background: Neck pain is one of the most prevalent musculoskeletal complaints affecting the adult population, particularly those engaged in sedentary occupations. With the rise in computer-based jobs, poor posture and prolonged sitting have emerged as significant contributors to cervical discomfort. This study was designed to assess the prevalence and severity of neck pain among employees working in software houses, offices, and other high-risk occupational environments in Bahawalpur, Pakistan. Objective: To determine the prevalence and severity of neck pain among adult employees working in various occupational settings in Bahawalpur. Methods: A cross-sectional study was conducted over a duration of three months. A total of 192 participants were recruited using a convenience sampling technique from occupations identified as high-risk, including software professionals, office staff, healthcare workers, drivers, and factory workers. Data were collected through a structured questionnaire, and the intensity of neck pain was evaluated using the Numeric Pain Rating Scale (NPRS), where participants rated their pain on a scale from 0 to 10. Data were analyzed using SPSS version 26, with findings presented in frequencies and percentages. Results: Out of 192 participants, 147 (76.6%) were aged 21–30 years, and 45 (23.4%) were aged 31–40 years. The sample included 124 (64.6%) males and 68 (35.4%) females. Overall, 131 participants (68.2%) reported experiencing neck pain. Among them, 70 (36.5%) reported mild pain, 51 (26.6%) had moderate pain, and 10 (5.2%) experienced severe or worst pain. A total of 61 (31.8%) participants reported no pain. Conclusion: There is a high prevalence of neck pain among employees working in sedentary occupations in Bahawalpur, with mild pain being the most frequently reported. These findings underline the need for ergonomic awareness and preventive strategies in workplace settings.
... NP causes physical and mental discomfort to patients and their families due to pain and disability and also seriously affects the quality of life, learning, and work efficiency. It also places a heavy burden on society, directly or indirectly, through costs related to healthcare, insurance, absenteeism, and lost productivity, affecting the health systems and economic fabric of countries [1,[4][5][6][7][8][9][10]. However, in the past, governments and funders have paid considerable attention to fatal chronic diseases such as cancer, cardiovascular disease, and respiratory disease, with little focus on chronic non-fatal diseases such as NP, which are highly prevalent [2]. ...
Article
Full-text available
Background This study aimed to comprehensively assess the magnitude, temporal trends, and inequalities associated with socioeconomic development in neck pain (NP) based on the Global Burden of Disease Study 2019. Methods An assessment of incidence and years of life with disability (YLD) at the global, regional, and country levels by age, sex and year was conducted for NP. Joinpoint regression (JPR) was used to analyze trends between 1990 and 2019. Decomposition analysis was used to explore the extent to which population growth, aging, and epidemiological changes influenced the changes in incidence and YLD. A Bayesian Age-Period-Cohort (BAPC) model was constructed to predict trends over the next 25 years. Concentration curve and concentration index were used to examine the cross-country relative inequality of the burden of NP at the socio-demographic index (SDI) level. Results In 2019, the global ASIR and ASDR of NP were 579.085 and 267.348 per 100,000 individuals, respectively. JPR analysis showed that the global ASIR and ASDR have decreased slightly over the past 30 years, although an increase was observed between 2011 and 2019. The BAPC model predicted that this upward trend would continue over the next 25 years. Decomposition analysis showed that the global increase in incidence and YLD in 2019 compared to 1990 was mainly driven by population growth. The burden of NP was higher in the middle-aged, old-age, and female groups, with differences in regional distribution. The analysis of cross-country inequality showed that the burden of NP was disproportionately concentrated in countries with a high SDI, and this phenomenon continued to increase over the 30-year study period. Conclusions Globally, NP remains an important public health problem, and governments are urgently required to raise public awareness about NP and its risk factors, implement targeted prevention and control policies, and deliver the necessary health services.
Article
Full-text available
Background This study describes the global epidemiology and trends associated with neck pain. Global Burden of Disease data collected between 1990 and 2019 were used to determine the global burden of neck pain in the general populations of 204 countries. Methods Global, regional, and national burdens of neck pain determined by prevalence, incidence, and years lived with a disability (YLD) from 1990 to 2019 were comprehensively analyzed according to age, gender, and socio-demographic index using the Global Burden of Disease Study 1990 and 2019 data provided by the Institute for Health Metrics and Evaluation. Results Globally, in 2019, the age-standardized rates for prevalence, incidence, and YLD of neck pain per 100,000 population was 2,696.5 (95% uncertainty interval [UI], 2,177.0 to 3,375.2), 579.1 (95% UI, 457.9 to 729.6), and 267.4 (95% UI, 175.5 to 383.5) per 100,000 population, respectively. Overall, there was no significant difference in prevalence, incidence, or YLD of neck pain between 1990 and 2019. The highest age-standardized YLD of neck pain per 100,000 population in 2019 was observed in high-income North America (479.1, 95% UI 323.0 to 677.6), Southeast Asia (416.1, 95% UI 273.7 to 596.5), and East Asia (356.4, 95% UI 233.2 to 513.2). High-income North America (17.0, 95% UI 9.0 to 25.4%) had the largest increases in YLD of neck pain per 100,000 population from 1990 to 2019. At the national level, the highest age-standardized YLD of neck pain was found in the Philippines (530.1, 95% UI 350.6 to 764.8) and the highest change age-standardized YLD between 1990 and 2019 was found in the United States (18.4, 95% UI 9.9 to 27.6%). Overall, the global burden of neck pain increased with age until the age of 70–74 years, and was higher in women than men. In general, positive associations between socio-demographic index and burden of neck pain were found. Conclusions Because neck pain is a major public health burden with a high prevalence, incidence, and YLD worldwide, it is important to update its epidemiological data and trends to cope with the future burden of neck pain.
Article
Full-text available
Background Neck pain is one of the most common musculoskeletal disorders, having an age-standardised prevalence rate of 27.0 per 1000 population in 2019. This literature review describes the global epidemiology and trends associated with neck pain, before exploring the psychological and biological risk factors associated with the initiation and progression of neck pain. Methods The PubMed database and Google Scholar search engine were searched up to May 21, 2021. Studies were included that used human subjects and evaluated the effects of biological or psychological factors on the occurrence or progression of neck pain, or reported its epidemiology. Results Psychological risk factors, such as long-term stress, lack of social support, anxiety, and depression are important risk factors for neck pain. In terms of the biological risks, neck pain might occur as a consequence of certain diseases, such as neuromusculoskeletal disorders or autoimmune diseases. There is also evidence that demographic characteristics, such as age and sex, can influence the prevalence and development of neck pain, although further research is needed. Conclusions The findings of the present study provide a comprehensive and informative overview that should be useful for the prevention, diagnosis, and management of neck pain.
Article
Full-text available
In conducting a systematic review, assessing the risk of bias of the included studies is a vital step; thus, choosing the most pertinent risk of bias (ROB) tools is crucial. This paper determined the most appropriate ROB tools for assessing observational studies in a systematic review assessing the association between anthropometric measurements and dental caries among children. First, we determined the ROB tools used in previous reviews on a similar topic. Subsequently, we reviewed articles on ROB tools to identify the most recommended ROB tools for observational studies. Of the twelve ROB tools identified from the previous steps, three ROB tools that best fit the eight criteria of a good ROB tool were the Newcastle–Ottawa Scale (NOS) for cohort and case-control studies, and Agency for Healthcare Research and Quality (AHRQ) and the Effective Public Health Practice Project (EPHPP) for a cross-sectional study. We further assessed the inter-rater reliability for all three tools by analysing the percentage agreement, inter-class correlation coefficient (ICC) and kappa score. The overall percentage agreements and reliability scores of these tools ranged from good to excellent. Two ROB tools for the cross-sectional study were further evaluated qualitatively against nine of a tool’s advantages and disadvantages. Finally, the AHRQ and NOS were selected as the most appropriate ROB tool to assess cross-sectional and cohort studies in the present review.
Article
Full-text available
Background Rehabilitation has often been seen as a disability-specific service needed by only few of the population. Despite its individual and societal benefits, rehabilitation has not been prioritised in countries and is under-resourced. We present global, regional, and country data for the number of people who would benefit from rehabilitation at least once during the course of their disabling illness or injury. Methods To estimate the need for rehabilitation, data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 were used to calculate the prevalence and years of life lived with disability (YLDs) of 25 diseases, impairments, or bespoke aggregations of sequelae that were selected as amenable to rehabilitation. All analyses were done at the country level and then aggregated to seven regions: World Bank high-income countries and the six WHO regions (ie, Africa, the Americas, Southeast Asia, Europe, Eastern Mediterranean, and Western Pacific). Findings Globally, in 2019, 2·41 billion (95% uncertainty interval 2·34–2·50) individuals had conditions that would benefit from rehabilitation, contributing to 310 million [235–392] YLDs. This number had increased by 63% from 1990 to 2019. Regionally, the Western Pacific had the highest need of rehabilitation services (610 million people [588–636] and 83 million YLDs [62–106]). The disease area that contributed most to prevalence was musculoskeletal disorders (1·71 billion people [1·68–1·80]), with low back pain being the most prevalent condition in 134 of the 204 countries analysed. Interpretation To our knowledge, this is the first study to produce a global estimate of the need for rehabilitation services and to show that at least one in every three people in the world needs rehabilitation at some point in the course of their illness or injury. This number counters the common view of rehabilitation as a service required by only few people. We argue that rehabilitation needs to be brought close to communities as an integral part of primary health care to reach more people in need. Funding Bill & Melinda Gates Foundation.
Article
Full-text available
Background How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure of disability-adjusted life-years (DALYs), a composite measure of disease burden capturing both premature mortality and prevalence and severity of ill health, for 359 diseases and injuries for 195 countries and territories over the past 28 years. Methods We used data for age-specific mortality rates, years of life lost (YLLs) due to premature mortality, and years lived with disability (YLDs) from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to calculate HALE and DALYs from 1990 to 2017. We calculated HALE using age-specific mortality rates and YLDs per capita for each location, age, sex, and year. We calculated DALYs for 359 causes as the sum of YLLs and YLDs. We assessed how observed HALE and DALYs differed by country and sex from expected trends based on Socio-demographic Index (SDI). We also analysed HALE by decomposing years of life gained into years spent in good health and in poor health, between 1990 and 2017, and extra years lived by females compared with males. Findings Globally, from 1990 to 2017, life expectancy at birth increased by 7·4 years (95% uncertainty interval 7·1–7·8), from 65·6 years (65·3–65·8) in 1990 to 73·0 years (72·7–73·3) in 2017. The increase in years of life varied from 5·1 years (5·0–5·3) in high SDI countries to 12·0 years (11·3–12·8) in low SDI countries. Of the additional years of life expected at birth, 26·3% (20·1–33·1) were expected to be spent in poor health in high SDI countries compared with 11·7% (8·8–15·1) in low-middle SDI countries. HALE at birth increased by 6·3 years (5·9–6·7), from 57·0 years (54·6–59·1) in 1990 to 63·3 years (60·5–65·7) in 2017. The increase varied from 3·8 years (3·4–4·1) in high SDI countries to 10·5 years (9·8–11·2) in low SDI countries. Even larger variations in HALE than these were observed between countries, ranging from 1·0 year (0·4–1·7) in Saint Vincent and the Grenadines (62·4 years [59·9–64·7] in 1990 to 63·5 years [60·9–65·8] in 2017) to 23·7 years (21·9–25·6) in Eritrea (30·7 years [28·9–32·2] in 1990 to 54·4 years [51·5–57·1] in 2017). In most countries, the increase in HALE was smaller than the increase in overall life expectancy, indicating more years lived in poor health. In 180 of 195 countries and territories, females were expected to live longer than males in 2017, with extra years lived varying from 1·4 years (0·6–2·3) in Algeria to 11·9 years (10·9–12·9) in Ukraine. Of the extra years gained, the proportion spent in poor health varied largely across countries, with less than 20% of additional years spent in poor health in Bosnia and Herzegovina, Burundi, and Slovakia, whereas in Bahrain all the extra years were spent in poor health. In 2017, the highest estimate of HALE at birth was in Singapore for both females (75·8 years [72·4–78·7]) and males (72·6 years [69·8–75·0]) and the lowest estimates were in Central African Republic (47·0 years [43·7–50·2] for females and 42·8 years [40·1–45·6] for males). Globally, in 2017, the five leading causes of DALYs were neonatal disorders, ischaemic heart disease, stroke, lower respiratory infections, and chronic obstructive pulmonary disease. Between 1990 and 2017, age-standardised DALY rates decreased by 41·3% (38·8–43·5) for communicable diseases and by 49·8% (47·9–51·6) for neonatal disorders. For non-communicable diseases, global DALYs increased by 40·1% (36·8–43·0), although age-standardised DALY rates decreased by 18·1% (16·0–20·2). Interpretation With increasing life expectancy in most countries, the question of whether the additional years of life gained are spent in good health or poor health has been increasingly relevant because of the potential policy implications, such as health-care provisions and extending retirement ages. In some locations, a large proportion of those additional years are spent in poor health. Large inequalities in HALE and disease burden exist across countries in different SDI quintiles and between sexes. The burden of disabling conditions has serious implications for health system planning and health-related expenditures. Despite the progress made in reducing the burden of communicable diseases and neonatal disorders in low SDI countries, the speed of this progress could be increased by scaling up proven interventions. The global trends among non-communicable diseases indicate that more effort is needed to maximise HALE, such as risk prevention and attention to upstream determinants of health.
Article
Full-text available
Background: Low back pain (LBP) remains a common health problem and one of the most prevalent musculoskeletal conditions found among developed and developing nations. The following paper reports on an updated search of the current literature into the prevalence of LBP among African nations and highlights the specific challenges faced in retrieving epidemiological information in Africa. Methods: A comprehensive search of all accessible bibliographic databases was conducted. Population-based studies into the prevalence of LBP among children/adolescents and adults living in Africa were included. Methodological quality of included studies was appraised using an adapted tool. Meta-analyses, subgroup analyses, sensitivity analyses and publication bias were also conducted. Results: Sixty-five studies were included in this review. The majority of the studies were conducted in Nigeria (n = 31;47%) and South Africa (n = 16;25%). Forty-three included studies (66.2%) were found to be of higher methodological quality. The pooled lifetime, annual and point prevalence of LBP in Africa was 47% (95% CI 37;58); 57% (95% CI 51;63) and 39% (95% CI 30;47), respectively. Conclusion: This review found that the lifetime, annual and point prevalence of LBP among African nations was considerably higher than or comparable to global LBP prevalence estimates reported. Due to the poor methodological quality found among many of the included studies, the over-representation of affluent countries and the difficulty in sourcing and retrieving potential African studies, it is recommended that future African LBP researchers conduct methodologically robust studies and report their findings in accessible resources. Trial registration: The original protocol of this systematic review was initially registered on PROSPERO with registration number CRD42014010417 on 09 July 2014.
Article
Full-text available
The Orthopaedic Section of the American Physical Therapy Association (APTA) has an ongoing effort to create evidence-based practice guidelines for orthopaedic physical therapy management of patients with musculoskeletal impairments described in the World Health Organization's International Classification of Functioning, Disability, and Health (ICF). The purpose of these revised clinical practice guidelines is to review recent peer-reviewed literature and make recommendations related to neck pain. J Orthop Sports Phys Ther. 2017;47(7):A1–A83. doi:10.2519/jospt.2017.0302
Article
Importance US health care spending has continued to increase and now accounts for 18% of the US economy, although little is known about how spending on each health condition varies by payer, and how these amounts have changed over time. Objective To estimate US spending on health care according to 3 types of payers (public insurance [including Medicare, Medicaid, and other government programs], private insurance, or out-of-pocket payments) and by health condition, age group, sex, and type of care for 1996 through 2016. Design and Setting Government budgets, insurance claims, facility records, household surveys, and official US records from 1996 through 2016 were collected to estimate spending for 154 health conditions. Spending growth rates (standardized by population size and age group) were calculated for each type of payer and health condition. Exposures Ambulatory care, inpatient care, nursing care facility stay, emergency department care, dental care, and purchase of prescribed pharmaceuticals in a retail setting. Main Outcomes and Measures National spending estimates stratified by health condition, age group, sex, type of care, and type of payer and modeled for each year from 1996 through 2016. Results Total health care spending increased from an estimated 1.4trillionin1996(13.31.4 trillion in 1996 (13.3% of gross domestic product [GDP]; 5259 per person) to an estimated 3.1trillionin2016(17.93.1 trillion in 2016 (17.9% of GDP; 9655 per person); 85.2% of that spending was included in this study. In 2016, an estimated 48.0% (95% CI, 48.0%-48.0%) of health care spending was paid by private insurance, 42.6% (95% CI, 42.5%-42.6%) by public insurance, and 9.4% (95% CI, 9.4%-9.4%) by out-of-pocket payments. In 2016, among the 154 conditions, low back and neck pain had the highest amount of health care spending with an estimated 134.5billion(95134.5 billion (95% CI, 122.4-146.9billion)inspending,ofwhich57.2146.9 billion) in spending, of which 57.2% (95% CI, 52.2%-61.2%) was paid by private insurance, 33.7% (95% CI, 30.0%-38.4%) by public insurance, and 9.2% (95% CI, 8.3%-10.4%) by out-of-pocket payments. Other musculoskeletal disorders accounted for the second highest amount of health care spending (estimated at 129.8 billion [95% CI, 116.3116.3-149.7 billion]) and most had private insurance (56.4% [95% CI, 52.6%-59.3%]). Diabetes accounted for the third highest amount of the health care spending (estimated at 111.2billion[95111.2 billion [95% CI, 105.7-115.9billion])andmosthadpublicinsurance(49.8115.9 billion]) and most had public insurance (49.8% [95% CI, 44.4%-56.0%]). Other conditions estimated to have substantial health care spending in 2016 were ischemic heart disease (89.3 billion [95% CI, 81.181.1-95.5 billion]), falls (87.4billion[9587.4 billion [95% CI, 75.0-100.1billion]),urinarydiseases(100.1 billion]), urinary diseases (86.0 billion [95% CI, 76.376.3-95.9 billion]), skin and subcutaneous diseases (85.0billion[9585.0 billion [95% CI, 80.5-90.2billion]),osteoarthritis(90.2 billion]), osteoarthritis (80.0 billion [95% CI, 72.272.2-86.1 billion]), dementias (79.2billion[9579.2 billion [95% CI, 67.6-90.8billion]),andhypertension(90.8 billion]), and hypertension (79.0 billion [95% CI, 72.672.6-86.8 billion]). The conditions with the highest spending varied by type of payer, age, sex, type of care, and year. After adjusting for changes in inflation, population size, and age groups, public insurance spending was estimated to have increased at an annualized rate of 2.9% (95% CI, 2.9%-2.9%); private insurance, 2.6% (95% CI, 2.6%-2.6%); and out-of-pocket payments, 1.1% (95% CI, 1.0%-1.1%). Conclusions and Relevance Estimates of US spending on health care showed substantial increases from 1996 through 2016, with the highest increases in population-adjusted spending by public insurance. Although spending on low back and neck pain, other musculoskeletal disorders, and diabetes accounted for the highest amounts of spending, the payers and the rates of change in annual spending growth rates varied considerably.
Book
This book focuses on Africa’s challenges, achievements, and failures over the past several centuries using an interdisciplinary approach that combines theory and fact and evidence-based practices and interventions in public health, and argues that most of the health problems in Africa are not a result of scarce or lack of resources, but of the misconceived and misplaced priorities that have left the continent behind every other on the globe in terms of health, education, and equitable distribution of opportunities and access to (quality) health as agreed by the United Nations member states at Alma-Ata in 1978.
Chapter
As study after study has pointed out, the health care systems in Africa pay little attention to the critical interface between education and good health, especially when it comes to the education of women and mothers, who are the primary line of defense against child diseases, and perform simultaneously most domestic chores and critical agricultural activities. While many medical educational institutions on the continent tend to perpetuate, at times, skewed and irrelevant Eurocentric health training, the national pyramidal health structure, weakened at the village level, and disproportionately favoring the provincial and national hospitals, gives the illusion that rural areas are well-served, when in actuality they are not. This chapter endorses the restrengthening of an uncompromised health care system to make it effective and efficient for both rural and urban areas; one that finds ways of trimming financial and human resource waste; revamps the institutions that train health care and service providers to make the system responsive to the real health needs of the people and not just the wealthy; one that compensates physicians just as civil servants; and aligns the educational system with targeted and expected measurable health outcomes.